HCW Biologics (HCWB) Cash & Current Investments (2020 - 2025)

HCW Biologics (HCWB) has 6 years of Cash & Current Investments data on file, last reported at $2.0 million in Q4 2025.

• Quarterly Cash & Current Investments fell 58.23% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (down 58.23% YoY) and the FY2025 annual result came in at $2.0 million, down 58.23% from the prior year.
• Cash & Current Investments advanced to $2.0 million in Q4 2025, from $1.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $60.0 million in Q1 2022 to a low of $82723.0 in Q2 2024.
• A 5-year average of $16.6 million and a median of $5.1 million in 2021 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments sank 99.52% — and 2025, when it surged 2848.35%.
• Tracing HCWB's Cash & Current Investments over 5 years: stood at $36.7 million in 2021, then dropped by 12.74% to $32.0 million in 2022, then slumped by 88.78% to $3.6 million in 2023, then surged by 30.03% to $4.7 million in 2024, then tumbled by 58.23% to $2.0 million in 2025.
• The last three Cash & Current Investments figures came in at $2.0 million (Q4 2025), $1.1 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.